2021: Year of the shot in the Arm

The experiences in the US, the UK, and several European countries over 2020 have demonstrated that the factory-to-syringe process can throw up several challenges, and that even the most resourceful of nations can struggle with a process that can be as labyrinthine as it needs to be precise.